RETINA Peptide Complex
activates retinal cells reserves increasing cell survivability and regenerative capacity when retina and optic nerve has been damaged. Retina Peptide Complex increases metabolism and blood flow, optimizes vascular permeability in eyes. It improves and stabilizes visual functions (visual acuity, low-light eyesight, visual field extension).
Compensated Primary open-Angle Glaucoma
Post-Traumatic and Post-Inflammatory Central Retinal Dystrophe (Macular Dystrophe)
Central Retinal Dystrophe (Macular Dystrophe)
Myopia (Within Comprehensive Treatment)
Central and Peripheral Tapetoretinal Abiotrophie
Retino Protectors are agents that protect retina from damage caused by exogenous and endogenous forces thus safeguarding eyesight from getting worse. Searching for new agents for retinal protection is a complicated process which requires integrated efforts of therapists, biologists and pharmacologists. Special attention should be given to peptide drugs. The benefits of these drugs are tissue specificity, absence of significant side-effects, short-course treatment and long-term clinical effect. Retina Peptide Complex is an example of successful drug development based on these principles. The efficacy of Retina Peptide Complex has been proven at the cellular and molecular levels. Retinal injuries may be caused by various factors and have different disease patterns, however, they are all accompanied by death of retinal neurons due to pathological processes with the similar molecular mechanisms. Among those mechanisms the most predominant one is excitotoxicity caused by over stimulation of Glutamate receptors followed by the influx of calcium ions. Excessive Ca2+ concentration triggers processes of cell death via necrosis or apoptosis.
SIDE EFFECTS AND PRECAUTIONS
No reported cases of adverse effects. Allergic reactions are possible in case of individual intolerance to any component of medication.
Store in dry protected from light place, at 2–20 °C.